← Open Payments lookup

CHRISTINE NGUYEN: Open Payments

NPI 1609375385 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,286 in 55 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $474 · 2025 $1,286

Food & beverage: $1,286
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.11$275
ABBVIE INC.10$231
Alkermes, Inc.8$194
Neurocrine BioSciences, Inc.7$170
Axsome Therapeutics, Inc.4$107
Takeda Pharmaceuticals U.S.A., Inc.5$86
Otsuka America Pharmaceutical, Inc.2$44
Bausch Health US, LLC2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$33
Almatica Pharma LLC1$30

Products named: COBENFY, VRAYLAR, INGREZZA, ARISTADA, Auvelity, TRINTELLIX, REXULTI, APLENZIN.

Industry payments across CA — which companies pay providers there.